GlassScriptPhysician profile
Mary K Dyes
NPI 1891737219
$7,909.75
in general payments reported to CMS, 2019-2025
47 companies · $1,032 in 2025
The $1,032 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $705 · 2020: $985 · 2021: $1,464 · 2022: $936 · 2023: $1,110 · 2024: $1,679 · 2025: $1,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,808 · Education: $13.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,808.26 |
| Education | $13.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,478.65 | 2019-2025 | Briviact, Fintepla, Nayzilam |
| Abbvie INC. | $1,149.86 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Sk Life Science, INC. | $605.59 | 2020-2025 | |
| Neurelis, INC. | $458.15 | 2020-2025 | Valtoco |
| Csl Behring | $370.95 | 2019-2025 | Hizentra |
| Biogen, INC. | $357.33 | 2020-2025 | Vumerity, Tysabri, Spinraza |
| Lundbeck LLC | $327.26 | 2021-2025 | Vyepti |
| Greenwich Biosciences, INC. | $285.82 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $250.67 | 2019-2022 | |
| Livanova USA, INC. | $220.85 | 2022-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Lilly USA, LLC | $168.02 | 2020-2024 | Emgality, Reyvow |
| Tris Pharma INC | $146.71 | 2019-2025 | Dyanavel Xr |
| Jazz Pharmaceuticals INC. | $137.19 | 2022-2024 | Epidiolex |
| Neuropace, INC. | $131.05 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $126.37 | 2020-2021 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Dyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.